Stelis Biopharma’s CDMO partner receives approval for key ANDA from the USFDA
The current approval is first of the many fillings made by the company's CDMO partners from the flagship facility in Bangalore
The current approval is first of the many fillings made by the company's CDMO partners from the flagship facility in Bangalore
Mock drills are being conducted across the country to review the preparedness for management of COVID-19
Centre and states need to work in tandem and in a collaborative spirit as was done during the previous surges for COVID-19 prevention and management
According to IQVIA sales data for the 12-month period ending October 2022, the Cardene Capsules, 20 mg and 30 mg market achieved annual sales of approximately US $10.9 million
The newly built centre will work as the state-of-the-art facility for not just ethical animal studies but spans from basic, applied to regulatory animal research.
India now has 648 medical colleges in 2022 with a whopping 96% increase in the number of Government Medical Colleges (GMC) alone and a 42% increase in the private sector, since 2014
Ayush market has reached US $18 billion from meager US $3 billion under guidance and visionary leadership of our Prime Minister
Glenmark’s Sodium Phenylbutyrate Tablets USP, 500 mg, will be distributed in the U.S. by Glenmark Pharmaceuticals USA.
Once the unit is made fully functional, it will help the company in increasing its API and intermediate production capacity
Subscribe To Our Newsletter & Stay Updated